Ann: Proteomics opens CLIA certified reference laboratory in USA, page-4

I know it's a slight delay in commercialisation and I also know the market has become very sketchy due to the US and other macro events.

I can even see that not having it as a market sensitive announcement and current low volumes have not helped.

However, based on the news today I am still very surprised at the fall. We have even gone below the Sonic deal cancellation share price plunge, and back to late 2020 prices.

Oh well, 30+ years and I still get unpleasantly surprised by the market, especially the spec end.

The cynic in me says we are being set up for a very low-ball CR. The optimist says revenue will start to flow soon. Maybe both are right.

Milesy